X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (115300) 115300
Newspaper Article (20973) 20973
Newsletter (6571) 6571
Magazine Article (830) 830
Book Chapter (570) 570
Trade Publication Article (214) 214
Dissertation (191) 191
Transcript (129) 129
Web Resource (103) 103
Book / eBook (56) 56
Government Document (46) 46
Reference (44) 44
Report (44) 44
Conference Proceeding (40) 40
Journal / eJournal (23) 23
Book Review (14) 14
Publication (13) 13
Paper (8) 8
Streaming Video (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (83510) 83510
hepatitis (52999) 52999
male (50729) 50729
female (49341) 49341
adult (39580) 39580
middle aged (36980) 36980
hepatitis c (23685) 23685
gastroenterology & hepatology (21761) 21761
hepatitis c virus (20078) 20078
aged (19148) 19148
health aspects (17773) 17773
infection (16426) 16426
hepatitis b (16050) 16050
liver (16031) 16031
infections (15498) 15498
risk factors (14831) 14831
infectious diseases (13599) 13599
prevalence (13161) 13161
adolescent (13023) 13023
animals (12387) 12387
immunology (12093) 12093
research (11883) 11883
liver diseases (11748) 11748
virology (11350) 11350
viruses (10516) 10516
interferon (10508) 10508
hepatitis b virus (10402) 10402
analysis (9549) 9549
antiviral agents - therapeutic use (9365) 9365
medical research (9104) 9104
disease (9057) 9057
patients (8619) 8619
genotype (8521) 8521
hepacivirus - genetics (8393) 8393
care and treatment (8334) 8334
virus diseases (8291) 8291
treatment outcome (8154) 8154
young adult (8085) 8085
liver cirrhosis (8038) 8038
hiv (7970) 7970
cirrhosis (7686) 7686
liver cancer (7634) 7634
epidemiology (7444) 7444
child (7116) 7116
diagnosis (6845) 6845
medicine (6838) 6838
retrospective studies (6816) 6816
hepatitis c - epidemiology (6662) 6662
medicine, general & internal (6539) 6539
human immunodeficiency virus--hiv (6392) 6392
liver - pathology (6392) 6392
antibodies (6295) 6295
therapy (6228) 6228
alanine transaminase - blood (6202) 6202
cancer (6159) 6159
research article (6034) 6034
hepatitis c, chronic - drug therapy (6012) 6012
antigens (5976) 5976
virus-infection (5900) 5900
hepatocellular carcinoma (5895) 5895
medicine, experimental (5892) 5892
rna, viral - blood (5889) 5889
transplantation (5871) 5871
risk (5748) 5748
studies (5728) 5728
hepatocellular-carcinoma (5696) 5696
surgery (5586) 5586
oncology (5560) 5560
mortality (5514) 5514
mice (5493) 5493
biopsy (5477) 5477
proteins (5378) 5378
microbiology (5377) 5377
polymerase chain reaction (5342) 5342
hepatitis-c virus (5281) 5281
hepatitis c - complications (5243) 5243
fibrosis (5200) 5200
digestive system diseases (5160) 5160
hcv (5144) 5144
hepatitis b virus - genetics (5088) 5088
time factors (5057) 5057
prognosis (5037) 5037
genetic aspects (4993) 4993
hematology (4942) 4942
interferon-alpha - therapeutic use (4923) 4923
viral load (4915) 4915
hepatology (4874) 4874
public health (4862) 4862
expression (4861) 4861
hepacivirus - immunology (4835) 4835
prospective studies (4749) 4749
hospitals (4730) 4730
vaccination (4730) 4730
vaccines (4722) 4722
hepatitis b surface antigens - blood (4712) 4712
rna (4697) 4697
gastroenterology and hepatology (4679) 4679
medicine & public health (4667) 4667
medicine, research & experimental (4659) 4659
hepatitis b - epidemiology (4645) 4645
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Robarts - Government Pubs (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (140472) 140472
French (1513) 1513
Spanish (953) 953
Portuguese (854) 854
Chinese (788) 788
German (759) 759
Japanese (652) 652
Russian (563) 563
Italian (306) 306
Polish (186) 186
Turkish (136) 136
Korean (126) 126
Romanian (71) 71
Hungarian (68) 68
Czech (41) 41
Croatian (39) 39
Swedish (31) 31
Urdu (30) 30
Norwegian (29) 29
Dutch (28) 28
Danish (26) 26
Persian (26) 26
Arabic (24) 24
Serbian (18) 18
Ukrainian (11) 11
Slovenian (9) 9
Slovak (8) 8
Bosnian (7) 7
Icelandic (7) 7
Finnish (5) 5
Bulgarian (4) 4
Hebrew (4) 4
Lithuanian (4) 4
Hindi (3) 3
Indonesian (2) 2
Afrikaans (1) 1
Albanian (1) 1
Breton (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of clinical investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for chronic infection is a combination of pegylated. IFN-alpha(2) and ribavirin (RBV... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
PloS one, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy.... 
VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1524-4636, 2014, Volume 34, Issue 5, pp. 1085 - 1092
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 10, p. e26971
.... Here we correlated serum miR-21 levels with clinical parameters in patients with different stages of chronic hepatitis C virus infection (CHC... 
CIRCULATING MICRORNAS | MIR-122 | ACTIVATION | SUPPRESSOR GENE | BIOMARKER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MIR-21 | INFECTION | EXPRESSION | TUMORS | Multivariate Analysis | Hepatitis C, Chronic - pathology | gamma-Glutamyltransferase - blood | Humans | Middle Aged | Liver Neoplasms - complications | Male | Alanine Transaminase - blood | Hepatitis C, Chronic - complications | Inflammation - blood | Necrosis | Liver Neoplasms - blood | Inflammation - complications | Carcinoma, Hepatocellular - complications | Hepatitis C, Chronic - enzymology | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - blood | Reproducibility of Results | Biomarkers - blood | Hepatitis C, Chronic - blood | Bilirubin - blood | Aspartate Aminotransferases - blood | Carcinoma, Hepatocellular - pathology | MicroRNAs - blood | Cohort Studies | Serum Albumin - metabolism | Infection | MicroRNA | Liver | Aspartate | Development and progression | Hepatoma | Bilirubin | Hepatitis C virus | Health aspects | Correlation | Colorectal cancer | Chronic infection | Viruses | Hepatocellular carcinoma | Alcohol | Infections | Multivariate analysis | Hepatitis | Liver cancer | miRNA | Alanine | Liver diseases | Ribonucleic acid--RNA | Patients | Medicine | Serum levels | Biopsy | MicroRNAs | Medical prognosis | Alanine transaminase | Biomarkers | Aspartate aminotransferase | Interferon | Hepatitis C | Prostate | Tumors | RNA | Ribonucleic acid
Journal Article
PloS one, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158641
.... Methods and Findings A comprehensive systems biology-based cross-sectional assessment of 130 peripheral blood B cell flow cytometry- and plasma-based features was performed on HIV-/Hepatitis C... 
RHEUMATOID-ARTHRITIS | DRUG-USERS | HIGH-RISK | EFFICACY TRIAL | MULTIDISCIPLINARY SCIENCES | VACCINE | IMMUNE ACTIVATION | BLOOD B-CELLS | OPIOID RECEPTORS | MICROBIAL TRANSLOCATION | HIV-1 INFECTION | HIV Antibodies - blood | Immunoglobulin G - blood | Immunity, Humoral - immunology | CD40 Ligand - blood | HIV Infections - epidemiology | Humans | Tumor Necrosis Factor-alpha - blood | Male | Immunoglobulin M - immunology | Substance Abuse, Intravenous - immunology | CD40 Ligand - immunology | Inflammation - blood | Young Adult | HIV Infections - immunology | Hepatitis C - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Transforming Growth Factor alpha - blood | Hepatitis C - blood | Hepatitis C - epidemiology | Tumor Necrosis Factor-alpha - immunology | Adult | Female | Heroin - administration & dosage | Interleukin-8 - blood | Substance Abuse, Intravenous - blood | HIV Infections - blood | Cross-Sectional Studies | Comorbidity | Narcotics - immunology | Substance Abuse, Intravenous - epidemiology | Inflammation - immunology | Inflammation - epidemiology | Heroin - immunology | Transforming Growth Factor alpha - immunology | Narcotics - administration & dosage | B-Lymphocytes - immunology | Immunoglobulin M - blood | Interleukin-8 - immunology | New York - epidemiology | Inflammation | Immune response | Health aspects | Analysis | Heroin habit | Health care | Immunoglobulin M | Drug abuse | Flow cytometry | Immunoglobulin G | Vaccination | Homeostasis | Infections | Vaccines | Multivariate analysis | Immunity | Hepatitis | Cell activation | Immunology | Metabolites | Human immunodeficiency virus--HIV | Peripheral blood | Ceramide | Aging | Immunity (humoral) | Interleukin 8 | Drug use | Public health | Heroin | Cytokines | Narcotics | Rheumatology | Injection | Tumor necrosis factor-α | Gene expression | Immune response (humoral) | Medicine | Learning algorithms | Cytometry | Infectious diseases | Lymphocytes B | Machine learning | Cocaine | Hepatitis C virus | Hepatitis C | Viral infections | HIV | Human immunodeficiency virus
Journal Article
Journal Article